Repligen Corporation (RGEN) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Repligen financial statements at a glance

Repligen reported revenue of $738.26 million for fiscal year 2025 (ended December 31, 2025), up 16.4% from fiscal year 2024. Net income was $48.89 million, a net margin of 6.6%, and diluted earnings per share were $0.86.

At the end of fiscal year 2025 it had total assets of $2.95 billion, total liabilities of $843.57 million and shareholders' equity of $2.11 billion, with cash and short-term investments of $767.63 million and total debt of $689.95 million.

Its operations brought in $117.42 million of cash; capital spending was $25.73 million, leaving free cash flow of $91.69 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

RGEN logo

Repligen Corporation

RGENUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
738.26M
Prev Year: 634.44M
YoY: +16.4%
Operating Revenue
738.26M
Prev Year: 634.44M
YoY: +16.4%
Tax Rate for Calcs
0.216
Prev Year: 0
Tax Effect of Unusual Items
8.90M
Prev Year: 1.83M
YoY: +386.7%
Total Unusual Items
41.18M
Prev Year: 32.64M
YoY: +26.2%
Total Unusual Items Excluding Goodwill
41.18M
Prev Year: 32.64M
YoY: +26.2%
Other Income Expense
44.00M
Prev Year: 27.46M
YoY: +60.2%
Other Non-operating Income (expense)
2.81M
Prev Year: -5.17M
YoY: +154.4%
Special Income Charges
13.61M
Prev Year: -3.19M
YoY: +526.4%
Restructuring and Mergers Acquisition
-13.61M
Prev Year: 3.19M
YoY: -526.4%
Gain on Sale of Securities
27.57M
Prev Year: 35.83M
YoY: -23.0%
Cost of Revenue
352.01M
Prev Year: 359.79M
YoY: -2.2%
Gross Profit
386.25M
Prev Year: 274.64M
YoY: +40.6%
Operating Expense
344.69M
Prev Year: 306.57M
YoY: +12.4%
Selling General and Administrative
290.51M
Prev Year: 263.37M
YoY: +10.3%
Research and Development
54.18M
Prev Year: 43.20M
YoY: +25.4%
Operating Income
41.56M
Prev Year: -31.92M
YoY: +230.2%
Net Non Operating Interest Income Expense
-23.17M
Prev Year: -22.57M
YoY: -2.7%
Non-operating Interest Expense
21.51M
Prev Year: 20.73M
YoY: +3.8%
Total Other Finance Cost
1.66M
Prev Year: 1.84M
YoY: -9.9%
Pre-tax Income
62.38M
Prev Year: -27.04M
YoY: +330.7%
Provision for Income Taxes
13.49M
Prev Year: -1.52M
YoY: +986.9%
Net Income Common Stockholders
48.89M
Prev Year: -25.51M
YoY: +291.6%
Net Income
48.89M
Prev Year: -25.51M
YoY: +291.6%
Net Income Including Non-Controlling Interests
48.89M
Prev Year: -25.51M
YoY: +291.6%
Net Income from Continuing Operations
48.89M
Prev Year: -25.51M
YoY: +291.6%
Diluted NI Available to Com Stockholders
48.89M
Prev Year: -25.51M
YoY: +291.6%
Basic EPS
0.87
Prev Year: -0.46
YoY: +289.1%
Diluted EPS
0.86
Prev Year: -0.46
YoY: +287.0%
Weighted Average Shares (basic)
56.23M
Prev Year: 55.94M
YoY: +0.5%
Weighted Average Shares (diluted)
56.56M
Prev Year: 55.94M
YoY: +1.1%
Total Operating Income as Reported
55.17M
Prev Year: -35.11M
YoY: +257.1%
Total Expenses
696.70M
Prev Year: 666.36M
YoY: +4.6%
Net Income from Continuing and Discontinued Operation
48.89M
Prev Year: -25.51M
YoY: +291.6%
Normalized Income
16.61M
Prev Year: -56.32M
YoY: +129.5%
Interest Expense
21.51M
Prev Year: 20.73M
YoY: +3.8%
Net Interest Income
-23.17M
Prev Year: -22.57M
YoY: -2.7%
EBIT
83.90M
Prev Year: -6.30M
YoY: +1430.8%
EBITDA
180.85M
Prev Year: 80.26M
YoY: +125.3%
Reconciled Cost of Revenue
352.01M
Prev Year: 359.79M
YoY: -2.2%
Reconciled Depreciation
96.96M
Prev Year: 86.56M
YoY: +12.0%
Net Income from Continuing Operation Net Minority Interest
48.89M
Prev Year: -25.51M
YoY: +291.6%
Normalized EBITDA
139.67M
Prev Year: 47.62M
YoY: +193.3%
Values in USD

Repligen key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$738.3M$634.4M$632.4M$801.5M$670.5M
Gross profit$386.2M$274.6M$278.4M$455.7M$391.3M
Operating income$41.6M-$31.9M$17.1M$195.9M$173.1M
Net income$48.9M-$25.5M$35.6M$186.0M$128.3M
Diluted EPS$0.86-$0.46$0.63$3.24$2.24
Total assets$2.9B$2.8B$2.8B$2.5B$2.4B
Total liabilities$843.6M$856.9M$866.3M$620.9M$608.3M
Shareholders' equity$2.1B$2.0B$2.0B$1.9B$1.8B
Cash and short-term investments$767.6M$757.4M$751.3M$623.8M$603.8M
Total debt$689.9M$686.2M$711.8M$423.0M$366.1M
Operating cash flow$117.4M$175.4M$113.9M$172.1M$119.0M
Capital spending$25.7M$32.9M$39.0M$133.3M$71.3M
Free cash flow$91.7M$142.5M$74.9M$38.7M$47.7M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Repligen's revenue in fiscal year 2025?

$738.26 million, up 16.4% from $634.44 million in fiscal year 2024.

How much profit does Repligen make?

Repligen reported net income of $48.89 million for fiscal year 2025 (6.6% of revenue); operating income was $41.56 million.

How much cash and debt does Repligen have?

At the end of fiscal year 2025: cash and short-term investments of $767.63 million and total debt of $689.95 million.

What is Repligen's free cash flow?

$91.69 million in fiscal year 2025 (operating cash flow of $117.42 million minus capital spending of $25.73 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube